Back

Integrative analyses identify potential key genes and pathways in Keshan disease using whole-exome sequencing

Li, X.; Huang, J.

2021-03-15 cardiovascular medicine
10.1101/2021.03.12.21253491 medRxiv
Show abstract

Keshan disease (KD), an endemic heart disease with multifocal necrosis and replacement fibrosis of the myocardium,is still a nightmare situation for human health. However, molecular mechanism in the pathogenesis of KD remains unclear. Herein, blood samples were collected from 68 KD patients and 100 controls, and we systematically analyzed mutation profiles using whole-exome sequencing (WES). Causative genes of dilated cardiomyopathy (DCM), gene-based burden analysis, disease and pathway enrichment analysis, and protein-protein interaction (PPI) network analysis were performed. Of the 98 DCM-causative genes, 106 rare variants in 28 genes were detected in KD patients with minor allele frequency (MAF) < 0.001. Gene-based burden analysis, PPI network analysis, and automated Phenolyzer analysis were performed to prioritize 199 candidate genes, which combined with 98 DCM-causative genes, and reference genes from gene microarray or proteomics in KD. Then, 19 candidate pathogenic genes were selected, and 9 candidate genes were identified using PPI analysis, including HIF1A, GART, ALAD, VCL, DTNA, NEXN, INPPL1, NOS3, and JAK2. The 199 candidate genes were further analyzed using disease enrichment with CTD database and PPI analysis, and 21 candidate genes were identified. By combining with disease enrichment and PPI analysis, 7 Selenium (Se)-related genes were further identified, including ALAD, RBM10, GSN, GGT1, ADD1, PARP1, and NOS3. Based on the gene function and data validation, NEXN, TAF1C, FUT4, ALAD, ZNF608, and STX2 were the most likely pathogenic genes in KD. Notably, ALAD is the only candidate pathogenic gene identified by four different analyses, and its homozygous mutant mice could affect heart development and cause death.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
eLife
5828 papers in training set
Top 10%
9.8%
2
Science Bulletin
21 papers in training set
Top 0.1%
7.9%
3
Frontiers in Cardiovascular Medicine
53 papers in training set
Top 0.4%
6.7%
4
Scientific Reports
3612 papers in training set
Top 11%
6.7%
5
Journal of Advanced Research
14 papers in training set
Top 0.1%
6.2%
6
PLOS ONE
5266 papers in training set
Top 31%
4.8%
7
Journal of Translational Medicine
57 papers in training set
Top 0.2%
4.0%
8
International Journal of Molecular Sciences
494 papers in training set
Top 4%
3.2%
9
Journal of the American Heart Association
140 papers in training set
Top 2%
3.2%
50% of probability mass above
10
Genes
144 papers in training set
Top 0.9%
3.1%
11
BMC Cardiovascular Disorders
18 papers in training set
Top 0.4%
2.4%
12
Medicine
31 papers in training set
Top 0.7%
2.1%
13
Biomedicines
67 papers in training set
Top 0.8%
2.0%
14
Frontiers in Genetics
230 papers in training set
Top 3%
1.7%
15
European Journal of Pharmacology
15 papers in training set
Top 0.2%
1.7%
16
Heliyon
152 papers in training set
Top 4%
1.5%
17
Computers in Biology and Medicine
128 papers in training set
Top 3%
1.4%
18
International Journal of Cardiology
14 papers in training set
Top 0.6%
1.4%
19
BMC Medical Genomics
50 papers in training set
Top 0.7%
1.3%
20
Journal of Clinical Medicine
97 papers in training set
Top 4%
1.1%
21
Frontiers in Neurology
102 papers in training set
Top 2%
1.1%
22
eBioMedicine
183 papers in training set
Top 4%
1.1%
23
JACC: Basic to Translational Science
21 papers in training set
Top 0.6%
1.1%
24
BMC Genomics
406 papers in training set
Top 7%
1.1%
25
European Heart Journal
22 papers in training set
Top 1%
1.1%
26
European Heart Journal - Digital Health
18 papers in training set
Top 0.8%
1.0%
27
Circulation: Genomic and Precision Medicine
48 papers in training set
Top 0.8%
1.0%
28
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.8%
29
Circulation: Heart Failure
14 papers in training set
Top 0.6%
0.8%
30
PLOS Genetics
862 papers in training set
Top 13%
0.6%